Clinic consultation informed by firsthand experience with clinical program directing and development, operationalizing, and delivering psychedelic treatment programs. Stephanie brings a systems-level understanding of the IV ketamine/Spravato clinical environment—from patient care and provider training to workflow, implementation, psychedelic clinical research, and program development—helping organizations translate emerging treatments into clinically sound, patient-centered practice.
Clinical Strategy Engagements are offered on a flat -fee basis determined by scope, complexity and organizational needs.
Clinic consultation informed by firsthand experience with clinical program directing and development, operationalizing, and delivering psychedelic treatment programs. Stephanie brings a systems-level understanding of the IV ketamine/Spravato clinical environment—from patient care and provider training to workflow, implementation, psychedelic clinical research, and program development—helping organizations translate emerging treatments into clinically sound, patient-centered practice.
Clinical Strategy Engagements are offered on a flat -fee basis determined by scope, complexity and organizational needs.